IDXX Idexx Laboratories Inc

Price (delayed)

$358.44

Market cap

$30.11B

P/E Ratio

41.44

Dividend/share

N/A

EPS

$8.65

Enterprise value

$31.17B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
IDXX's price to earnings (P/E) is 41% lower than its last 4 quarters average of 70.7 and 31% lower than its 5-year quarterly average of 60.1
IDXX's revenue is up by 15% year-on-year
The quick ratio has decreased by 47% YoY and by 7% QoQ
The debt has grown by 29% YoY and by 25% from the previous quarter

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
84.01M
Market cap
$30.11B
Enterprise value
$31.17B
Valuations
Price to earnings (P/E)
41.44
Price to book (P/B)
47.2
Price to sales (P/S)
9.24
EV/EBIT
33.4
EV/EBITDA
29.99
EV/Sales
9.52
Earnings
Revenue
$3.27B
EBIT
$933.31M
EBITDA
$1.04B
Free cash flow
$614.61M
Per share
EPS
$8.65
Free cash flow per share
$7.28
Book value per share
$7.59
Revenue per share
$38.79
TBVPS
$25.19
Balance sheet
Total assets
$2.59B
Total liabilities
$1.95B
Debt
$1.26B
Equity
$639.8M
Working capital
$118.43M
Liquidity
Debt to equity
1.97
Current ratio
1.12
Quick ratio
0.62
Net debt/EBITDA
1.02
Margins
EBITDA margin
31.7%
Gross margin
58.6%
Net margin
22.4%
Operating margin
28.5%
Efficiency
Return on assets
29.9%
Return on equity
103.8%
Return on invested capital
44.1%
Return on capital employed
57.6%
Return on sales
28.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
2.2%
1 week
-0.84%
1 month
-3.03%
1 year
-43.9%
YTD
-45.56%
QTD
2.2%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.27B
Gross profit
$1.92B
Operating income
$932.75M
Net income
$734.55M
Gross margin
58.6%
Net margin
22.4%
IDXX's operating income is up by 17% YoY
IDXX's revenue is up by 15% year-on-year
The gross profit has increased by 14% YoY
The company's net income rose by 9% YoY

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
41.44
P/B
47.2
P/S
9.24
EV/EBIT
33.4
EV/EBITDA
29.99
EV/Sales
9.52
IDXX's price to earnings (P/E) is 41% lower than its last 4 quarters average of 70.7 and 31% lower than its 5-year quarterly average of 60.1
The company's EPS rose by 9% YoY
The price to book (P/B) is 36% less than the last 4 quarters average of 73.8
The company's equity fell by 9% YoY and by 7% QoQ
The P/S is 44% below the last 4 quarters average of 16.5 and 19% below the 5-year quarterly average of 11.4
IDXX's revenue is up by 15% year-on-year

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 21% YoY
Idexx Laboratories's return on invested capital has increased by 13% YoY but it has decreased by 2% QoQ
The return on assets has declined by 4.2% since the previous quarter and by 4.2% year-on-year
The company's return on sales rose by 2.2% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 33% higher than its total liabilities
The quick ratio has decreased by 47% YoY and by 7% QoQ
IDXX's current ratio is down by 37% year-on-year and by 10% since the previous quarter
The debt is 97% more than the equity
IDXX's debt to equity is up by 41% YoY and by 34% QoQ
The debt has grown by 29% YoY and by 25% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.